Kimihiro Shimizu Selected Research

Thymoma (Thymic Carcinoma)

1/2023	Successful resection after first-line lenvatinib therapy in an advanced thymic carcinoma.
2/2019	Carbonic anhydrase 9 expression is associated with poor prognosis, tumor proliferation, and radiosensitivity of thymic carcinomas.
6/2009	L-type amino acid transporter 1 (LAT1) is frequently expressed in thymic carcinomas but is absent in thymomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kimihiro Shimizu Research Topics

Disease

61	Neoplasms (Cancer) 12/2023 - 07/2005
34	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2023 - 07/2005
33	Lung Neoplasms (Lung Cancer) 12/2023 - 09/2002
12	Adenocarcinoma 07/2020 - 06/2007
10	Adenocarcinoma of Lung 11/2023 - 01/2010
10	Carcinoma (Carcinomatosis) 11/2023 - 07/2010
8	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2020 - 02/2009
6	Sarcoma (Soft Tissue Sarcoma) 10/2022 - 12/2008
6	Neoplasm Metastasis (Metastasis) 09/2019 - 02/2009
4	Fistula 03/2023 - 02/2005
4	Hemorrhage 01/2022 - 02/2005
4	Hypoxia (Hypoxemia) 01/2020 - 01/2018
4	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 04/2013
3	Lymphatic Metastasis 01/2023 - 09/2010
3	Thymoma (Thymic Carcinoma) 01/2023 - 06/2009
3	Wounds and Injuries (Trauma) 01/2022 - 01/2013
3	Neuroendocrine Tumors (Neuroendocrine Tumor) 10/2021 - 01/2008
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2019 - 07/2010
3	Pneumothorax 05/2016 - 01/2013
2	Pneumonia (Pneumonitis) 03/2023 - 10/2015
2	Empyema 03/2023 - 05/2017
2	Diarrhea 01/2023 - 10/2015
2	Interstitial Lung Diseases (Interstitial Lung Disease) 07/2020 - 06/2007
2	Small Cell Carcinoma 01/2019 - 10/2010
2	Large Cell Carcinoma 01/2019 - 10/2010
2	Chylothorax 01/2005 - 09/2002
1	Atrial Fibrillation 12/2023
1	Mediastinal Emphysema (Pneumomediastinum) 02/2023
1	Hypertension (High Blood Pressure) 01/2023
1	Pericardial Effusion 01/2023
1	Rhabdomyosarcoma 10/2022
1	Pain (Aches) 01/2022
1	Mesothelioma 01/2022
1	Bronchopulmonary Sequestration (Pulmonary Sequestration) 03/2021
1	Anaphylaxis (Anaphylactic Shock) 01/2021

Drug/Important Bio-Agent (IBA)

18	ErbB Receptors (EGF Receptor)IBA 12/2023 - 06/2007
16	Amino Acid Transport Systems (Amino Acid Transporter)IBA 01/2019 - 11/2007
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2010 - 12/2008
7	Tyrosine Kinase InhibitorsIBA 01/2021 - 06/2007
6	Gefitinib (Iressa)FDA Link 09/2020 - 06/2007
6	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2019 - 04/2009
5	Proteins (Proteins, Gene)FDA Link 11/2023 - 07/2010
5	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 11/2011
5	Carcinoembryonic AntigenIBA 01/2019 - 07/2005
4	Biomarkers (Surrogate Marker)IBA 09/2020 - 10/2013
4	NivolumabIBA 03/2020 - 01/2018
4	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2020 - 01/2018
4	Gemcitabine FDA Link 10/2013 - 03/2008
4	Deoxyglucose (2 Deoxy D glucose)IBA 11/2011 - 11/2007
4	Heavy Chain Fusion Regulatory Protein 1IBA 09/2010 - 02/2009
3	LigandsIBA 12/2023 - 01/2020
3	Messenger RNA (mRNA)IBA 11/2023 - 07/2010
3	RNA (Ribonucleic Acid)IBA 10/2022 - 01/2017
3	Anaplastic Lymphoma KinaseIBA 01/2021 - 09/2019
3	Amino Acids FDA Link 01/2020 - 08/2011
3	FluorineIBA 01/2018 - 08/2011
3	Indicators and Reagents (Reagents)IBA 03/2017 - 07/2005
3	DNA (Deoxyribonucleic Acid)IBA 09/2014 - 06/2007
2	PhosphoproteinsIBA 10/2021 - 10/2017
2	StathminIBA 09/2020 - 10/2017
2	CrizotinibIBA 07/2020 - 09/2019
2	Immune Checkpoint InhibitorsIBA 03/2020 - 03/2018
2	Tyrosine (L-Tyrosine)FDA Link 01/2020 - 11/2010
2	Cisplatin (Platino)FDA LinkGeneric 11/2018 - 09/2009
2	Codon (Codons)IBA 09/2014 - 01/2010
1	CateninsIBA 11/2023
1	Leucine (L-Leucine)FDA Link 11/2023
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 11/2023
1	lenvatinibIBA 01/2023
1	Phosphotransferases (Kinase)IBA 01/2023
1	TeaIBA 01/2022
1	SynaptophysinIBA 10/2021
1	Hematoxylin (Haematoxylon)IBA 10/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 10/2021
1	Chromogranin AIBA 10/2021
1	monoclonal antibody E9X9VIBA 06/2021
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 03/2021
1	Contrast MediaIBA 01/2021

Therapy/Procedure

14	Segmental Mastectomy (Lumpectomy) 03/2023 - 10/2010
10	Therapeutics 01/2023 - 11/2011
9	Thoracotomy 12/2023 - 08/2005
6	Drug Therapy (Chemotherapy) 10/2021 - 06/2007
6	Lymph Node Excision (Lymph Node Dissection) 01/2014 - 09/2002
4	Metastasectomy 01/2019 - 04/2013
2	Pleurodesis 03/2023 - 05/2016
2	Length of Stay 02/2023 - 10/2014
2	Molecular Targeted Therapy 10/2022 - 09/2014
2	Minimally Invasive Surgical Procedures 06/2021 - 10/2014
2	Radiotherapy 01/2021 - 09/2009
2	Local Anesthesia 05/2019 - 01/2011
2	Adjuvant Chemotherapy 11/2018 - 10/2016
2	Surgical Instruments (Clip) 09/2016 - 01/2014
2	Chest Tubes (Chest Tube) 01/2005 - 09/2002
1	Drug Tapering 01/2023
1	Neoadjuvant Therapy 01/2022
1	Operative Time 01/2022
1	Analgesia 01/2022
1	Surgical Staplers (Surgical Stapler) 01/2022
1	Intravenous Administration 03/2021
1	Chemoradiotherapy 01/2021